Why Supplement Quality Control Testing Matters for Brand Owners

At SREKE, we understand that the reputation of your supplement brand depends on what happens behind the scenes — and that starts with rigorous quality control testing. The dietary supplement industry is regulated under the FDA's Current Good Manufacturing Practices (cGMP) in 21 CFR Part 111, which mandates specific testing requirements before any product can be released to market. For brand owners, skipping or shortcuts on quality control isn't just a compliance risk — it's a brand-risk that can lead to recalls, negative reviews, and loss of consumer trust.

Our GMP-certified manufacturing facility in Guangzhou implements a multi-layered quality assurance system that covers raw material verification, in-process testing, and finished product release. Every batch we produce undergoes identity testing, assay confirmation, heavy metal screening, microbiological analysis, and stability evaluation before it leaves our facility. When you partner with us, these standards become your standards.

The Real Cost of Inadequate Testing

Industry data from the Natural Products Association shows that supplement recalls and quality failures cost brands an average of $500,000 to $2 million per incident when you factor in recall logistics, legal exposure, and reputational damage. A single contaminated batch can erase years of brand-building effort. At SREKE, we treat every incoming raw material lot as a potential risk until proven otherwise through verified analytical results.

Key Manufacturing Considerations at SREKE

Our team evaluates multiple testing parameters for every formulation we develop. Below is how we approach the most critical quality control methods that directly affect your product's safety, label accuracy, and regulatory compliance.

1. Identity Testing — Confirming What You Receive

Identity testing is the first line of defense in our quality system. Before any raw material enters our production floor, we verify it using one or more of the following methods:

• FTIR (Fourier Transform Infrared Spectroscopy): We use FTIR to compare the molecular fingerprint of each ingredient against an authenticated reference standard. This is the method specified under FDA cGMP 21 CFR §111.65 for verifying the identity of each component used in manufacturing.
• HPLC (High-Performance Liquid Chromatography): For botanical extracts and complex blends, we employ HPLC profiling to confirm the presence of marker compounds unique to the declared ingredient. This helps distinguish genuine material from substitutes or adulterants.
• Microscopy and Organoleptic Analysis: We conduct visual and microscopic examination of powders, capsules, and raw materials as a supplementary identification check consistent with USP <776> guidelines.

2. Assay and Potency Testing — Ensuring Label Accuracy

Assay testing confirms that the active ingredients in your product match the amounts declared on the label. At SREKE, we perform quantitative analysis using validated HPLC or UV-Vis spectrophotometry methods for each active component. Our acceptance criteria typically require assay results to fall within 90%–110% of the labeled claim, which aligns with USP general chapter <905> Uniformity of Dosage Units and FDA cGMP requirements.

We also account for degradation over shelf life by conducting accelerated stability studies per ICH Q1A(R2) guidelines. This ensures your product delivers the potency it promises throughout its entire labeled shelf life — not just on day one.

3. Heavy Metal Testing — Protecting Consumer Safety

Heavy metals such as lead, arsenic, cadmium, and mercury are naturally occurring contaminants that can accumulate in botanical and mineral-derived ingredients. Under California Proposition 65 and global regulatory expectations, brands must demonstrate that their products contain heavy metals below established safe-harbor thresholds.

At SREKE, we analyze heavy metals using ICP-MS (Inductively Coupled Plasma Mass Spectrometry), which provides detection limits in the parts-per-billion range. Our internal specifications are often stricter than the USP <232> and <233> limits, giving you an additional margin of safety. We also source heavy-metal screening certificates from our suppliers as part of our vendor qualification process.

4. Microbiological Testing — Preventing Contamination

Microbiological testing is non-negotiable for any supplement that will be consumed orally. Our facility tests for total aerobic microbial count, yeast and mold, E. coli, Salmonella species, and other specified organisms in accordance with USP <61> and <62> procedures. We also monitor our cleanroom environments regularly using environmental sampling protocols consistent with ISO 14644-1 classifications for our controlled manufacturing areas.

• Total Aerobic Microbial Count (TAMC): Measured per USP <61>, with acceptance criteria defined by the product type and route of administration.
• Yeast and Mold Count (TYMC): Evaluated alongside TAMC to ensure no fungal contamination.
• Absence of Specified Pathogens: E. coli and Salmonella must be absent in 1g or 10g samples, as required by FDA cGMP.

5. Pesticide Residue and Adulterant Screening

Botanical ingredients are particularly susceptible to pesticide residues and intentional adulteration. At SREKE, we require multi-residue pesticide screening from our suppliers using GC-MS/MS and LC-MS/MS methodologies. We also screen for undeclared pharmaceutical adulterants in herbal products — a practice recommended by the FDA's All-Plant Database and supported by our own incoming material verification protocol.

6. Dissolution and Disintegration Testing

For tablet and capsule formulations, dissolution and disintegration testing ensures that the product releases its active ingredients at the rate your consumers expect. We conduct these tests using USP Apparatus 1 (basket) and Apparatus 2 (paddle) methods, with time-point sampling calibrated to each product's specific formulation characteristics. This testing is especially important for hard-shell capsule and compressed tablet products where bioavailability directly impacts product performance.

7. Packaging Integrity and Compatibility Testing

Quality control at SREKE extends beyond the formula itself. We test packaging materials for compatibility with the product contents, including moisture barrier performance, light protection, and seal integrity. For gummy and liquid products, we evaluate child-resistant closure performance and package extractables to ensure no migration of packaging components into the product.

How SREKE Helps You Get to Market Faster

At SREKE, we know that speed-to-market is critical for supplement brands. Our integrated quality control infrastructure allows us to streamline the testing-and-release process without compromising compliance. Here's how we help you launch faster:

• Pre-qualified ingredient library: We maintain an approved supplier list with pre-vetted Certificates of Analysis (CoAs) for over 800 raw materials, reducing incoming testing timelines significantly.
• In-house QC laboratory: Our on-site laboratory handles routine identity, assay, and microbiological testing internally, eliminating third-party lab turnaround delays.
• Parallel processing: While production runs, our QC team begins stability and release testing simultaneously, compressing the overall timeline.
• Flexible MOQs: We support low minimum order quantities for brand owners testing new formulations, so you can validate market demand before committing to large production runs.
• Lead time transparency: Standard OEM orders ship within 4–8 weeks depending on product type and packaging complexity. We provide real-time production tracking so you always know where your order stands.

Whether you're launching a new softgel formula, reformulating an existing product, or expanding into gummies and liquids, our team works with you to optimize the formulation, packaging, and testing plan for your specific market — whether that's the United States, the European Union, or other regulated markets worldwide.

Industry Trends and Market Opportunities

The supplement industry continues to evolve, and quality control testing is at the center of those changes. At SREKE, we track several trends that directly impact how brand owners should approach product development and manufacturing partnerships.

Rising Regulatory Scrutiny

The FDA has increased inspection frequency and enforcement actions against supplement manufacturers in recent years. The 2023–2025 period saw a notable rise in warning letters related to cGMP deviations, misbranding, and adulterated products. Third-party certification bodies such as NSF, UL, and Informed Choice are also raising testing bar for their certifications. Brands that proactively invest in robust quality systems are better positioned to meet these expectations.

Consumer Demand for Transparency

Modern consumers increasingly request third-party testing documentation, CoAs, and sustainability certifications before purchasing supplements. At SREKE, we provide batch-specific CoAs and can arrange independent third-party testing through accredited laboratories such as Eurofins or ALS Global upon request. This transparency builds consumer confidence and supports your brand's positioning in competitive retail channels.

Gummies and Functional Foods Growth

The functional gummy segment continues to experience double-digit year-over-year growth. However, gummy formulations present unique quality control challenges — including moisture control, microbial stability, and vitamin retention during storage. Our facility has dedicated gummy production lines with specialized environmental controls, and we conduct additional stability testing tailored to this dosage form.

Sustainability and Clean-Label Formulations

Brand owners are increasingly requesting clean-label, non-GMO, and sustainably sourced ingredients. These demands require additional verification testing — including GMO screening per ISO/TS 22003-4 guidelines and supply-chain traceability audits. SREKE supports these initiatives by sourcing certified ingredients and providing the documentation your marketing team needs.

Frequently Asked Questions

What testing does SREKE perform on every batch?

At SREKE, every produced batch undergoes identity testing of all active ingredients, assay/potency confirmation, heavy metal screening, microbiological analysis, and organoleptic evaluation. Finished products also receive packaging integrity checks before release. We retain full batch records and CoAs for the duration required by FDA cGMP regulations.

Can you work with my existing formulation?

Yes. We accept custom formulations from brand owners and conduct full quality review during our formulation assessment phase. If your formula requires adjustments for manufacturability, regulatory compliance, or stability, our R&D team will recommend modifications and retest the revised version before production begins.

What is your typical MOQ for OEM orders?

Our MOQ varies by product type. Softgels and capsules typically start at 5,000–10,000 units, tablets at 10,000–20,000 units, powders at 1 kg minimum, and gummies at 5,000–10,000 units. We offer flexible MOQ options for startups and growing brands — contact our team for a customized quote.

Do you provide third-party testing certificates?

We provide in-house CoAs for every batch. For brands that require independent third-party verification, we can arrange testing through accredited external laboratories at additional cost and lead time. We also support NSF, UL, and Informed Choice certification processes.

What is your standard lead time from order to delivery?

Standard lead time is 4–8 weeks depending on product type, formulation complexity, packaging requirements, and testing needs. Rush production is available for select products. We provide detailed timelines during the quoting process so you can plan your launch with confidence.

Are your facilities certified for international markets?

Our Guangzhou facility holds GMP certification and is registered with China's NMPA. We also comply with FDA cGMP (21 CFR Part 111), EU Directive 2002/46/EC for food supplements, and HACCP principles. Our quality management system supports export documentation requirements for the US, EU, Australia, Canada, and other regulated markets.

How do you handle private label versus custom OEM development?

Private label products use our existing formula library with your branding — these typically have shorter lead times and lower MOQs. Custom OEM development involves formulating a unique product from scratch, which includes R&D, testing, and regulatory review before production. Our team guides you through both paths and recommends the best approach based on your timeline and budget.

Ready to launch your supplement brand? SREKE provides GMP-certified OEM/ODM manufacturing for softgels, capsules, tablets, powders, gummies, and liquids. Contact us for a free quote or email [email protected] — we respond within 24 hours.